What We do
SEQUENCIVE Labs solve complex problems by enabling researchers, universities, and enterprises through IP creation and commercialization.
Problem
Offerings
Helping You Commercialize DeepTech & Localize Technology at Scale.
Researchers
- - Co-innovating for Market Fit.
- - Scalable Go-to-Market.
TTOs
- - Commercial Scale Validation.
- - IP Portfolio Assessment & Valuation.
Enterprises
- - Ready to Deploy Technology.
- - Lab as a Service.
Use Cases
IP Based SEQUENCIVE Venture
PHYLA created DeepTech IP and industrial processes to produce alternative protein from organic waste.
PHYLA Alternative Protein
%204.png)
IP Based SEQUENCIVE Venture
WOLVEE is a Saudi company that develops and acquires DeepTech IP in Space, IoT, and AI to advance the Kingdom's technological sovereignty.
WOLVEE navigator
Floranova
Exclusive Commercialized IP
Joint venture with KAUST specialized in developing plant propagation protocols and disease resistant plants.
Saudi Coffee Tissue Culture
KHADR
Exclusive Commercialized IP
Joint venture with KAUST that produce advanced biostimulants designed to enhance crops yield.
.png)
Biostimulant Technology
Partners
Newsroom
.png)
%201.png)
